ClinicalTrials.Veeva

Menu
C

Colorado Allergy and Asthma Centers, PC | Denver, CO

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Fluticasone Propionate
PF-03715455
Azelastine
albuterol
Albuterol
Ciclesonide
BLU-5937
Dupilumab
azelastine hydrochloride
Azelastine hydrochloride

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 10 total trials

A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2)

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Enrolling
Refractory Chronic Cough
Drug: Placebo
Drug: BLU-5937

Trial sponsors

Meda Pharmaceuticals logo
Teva Pharmaceuticals logo
B
Novartis logo
Pfizer logo
Sanofi logo
Sumitomo Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems